Inflammatory faCtors AfteR acUte Ischemic Stroke

Recruiting N/A Interventional Study
Ischemic Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
36 (estimated)
Sponsor
Martin Dichgans · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
ICARUS is an interventional single-centre hospital-based cohort study in patients admitted to the stroke unit with an acute ischemic stroke. The aims of the study are to i) define the characteristics and determinants of microglial activation after human stroke, and ii) assess the correlation of microglial activation with circulating inflammatory markers, structural brain changes on neuroimaging, a…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 50 years * Acute ischemic stroke (time frame: \<72 hours) as defined by an acute focal neurological deficit in combination with a corresponding infarct as documented by a diffusion weighted imaging (DWI)-positive lesion on magnetic resonance imaging (MRI); presence of an…
Contacts

Martin Dichgans, Prof.

+49 4400

martin.dichgans@med.uni-muenchen.de

CONTACT

Anna Kopczak, MD

+49 4400

anna.kopczak@med.uni-muenchen.de

CONTACT